Fundraising Fox
/Companies
Sign in

Advesya

Besançon, FR · 1 known investors

Find your way into Advesya

Sign up to see every warm intro you have to Advesya

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Advesya team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Advesya is a clinical-stage biotech company developing cancer and autoimmune disease therapies that target IL-1RAP, an antigen upregulated in various cancers and autoimmune conditions. A spin-out from the French Blood Institute (EFS), it is developing a CAR T-cell therapy (CCTx-001) and an antibody-drug conjugate (ADV-101).

BiotechHealthtechMedical Devices

Founders & leadership

CFChristophe Ferrand
Christophe FerrandFounder and Board Member (Director of R&D)
MDMarina Deschamps
Marina DeschampsFounder (Director of CMC)Marina Deschamps spent over 19 years in translational immunotherapy research at the French Blood Institute (EFS), where she led gene therapy clinical trials and specialized in CAR T-cell engineering and manufacturing processes; she is now Founder and CTO of Advesya, developing cell and gene therapies for cancer and autoimmune diseases.
ABAndré Baruchel
André BaruchelFounder and Board MemberPrincipal, PhD at Biovance Capital Partners SCR

Board

KPKsenija Pavletic
Ksenija PavleticA.I. Chief Executive OfficerGeneral Partner & Chief Commercial Officer at Jeito Capital

Investors · 1

Frequently asked questions

What does Advesya do?
Advesya is a clinical-stage biotech company developing cancer and autoimmune disease therapies that target IL-1RAP, an antigen upregulated in various cancers and autoimmune conditions. A spin-out from the French Blood Institute (EFS), it is developing a CAR T-cell therapy (CCTx-001) and an antibody-drug conjugate (ADV-101).
Who founded Advesya?
Advesya was founded by Christophe Ferrand, Marina Deschamps, André Baruchel.
Who are Advesya's investors?
Advesya's investors include Jeito Capital.
Where is Advesya headquartered?
Advesya is headquartered in Besançon, FR.